Acarix As Stock Short Ratio
| ACARIX Stock | SEK 0.30 0.01 3.23% |
Acarix AS fundamentals help investors to digest information that contributes to Acarix AS's financial success or failures. It also enables traders to predict the movement of Acarix Stock. The fundamental analysis module provides a way to measure Acarix AS's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Acarix AS stock.
Acarix |
Acarix AS Company Short Ratio Analysis
Acarix AS's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Based on the latest financial disclosure, Acarix AS has a Short Ratio of 0.0 times. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and 100.0% lower than that of the Health Care industry. The short ratio for all Sweden stocks is 100.0% higher than that of the company.
Did you try this?
Run Theme Ratings Now
Theme RatingsDetermine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Acarix Fundamentals
| Return On Equity | -1.46 | |||
| Return On Asset | -0.8 | |||
| Operating Margin | (13.75) % | |||
| Current Valuation | 51.77 M | |||
| Shares Outstanding | 373.33 M | |||
| Shares Owned By Insiders | 10.28 % | |||
| Shares Owned By Institutions | 2.84 % | |||
| Price To Book | 1.63 X | |||
| Price To Sales | 15.38 X | |||
| Revenue | 3.76 M | |||
| Gross Profit | 2.82 M | |||
| EBITDA | (48.28 M) | |||
| Net Income | (51.73 M) | |||
| Cash And Equivalents | 15.86 M | |||
| Cash Per Share | 2.24 X | |||
| Total Debt | 239 K | |||
| Debt To Equity | 2.30 % | |||
| Current Ratio | 7.38 X | |||
| Book Value Per Share | 0.20 X | |||
| Cash Flow From Operations | (48.01 M) | |||
| Earnings Per Share | (0.31) X | |||
| Target Price | 0.75 | |||
| Beta | 1.65 | |||
| Market Capitalization | 107.15 M | |||
| Total Asset | 118.6 M | |||
| Net Asset | 118.6 M |
About Acarix AS Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Acarix AS's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Acarix AS using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Acarix AS based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Acarix Stock
Acarix AS financial ratios help investors to determine whether Acarix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Acarix with respect to the benefits of owning Acarix AS security.